Upper respiratory tract toxicity of inhaled methylvinyl ketone in F344 rats and B6C3F1 mice

• Published in: Toxicological sciences Vol. 58; no. 1; pp. 182 - 194
• Main Authors: MORGAN, Daniel L, PRICE, Herman C, O'CONNOR, Robert W, SEELY, John C, WARD, Sandra M, WILSON, Ralph E, CUNNINGHAM, Michael C
• Format: Journal Article
• Language: English
• Published: Cary, NC Oxford University Press 01.11.2000
• Subjects: Administration, Inhalation; Animals; Biological and medical sciences; Body Weight - drug effects; Butanones - administration & dosage; Butanones - toxicity; Chemical and industrial products toxicology. Toxic occupational diseases; Female; Kidney - drug effects; Kidney - pathology; Liver - drug effects; Liver - pathology; Lung - drug effects; Lung - pathology; Male; Medical sciences; methyl vinyl ketone; Mice; Mice, Inbred Strains; Nasal Cavity - drug effects; Nasal Cavity - pathology; Necrosis; Organ Size - drug effects; Rats; Rats, Inbred F344; Respiratory Mucosa - drug effects; Respiratory Mucosa - pathology; Sperm Count; Sperm Motility - drug effects; Testis - drug effects; Testis - pathology; Toxicity Tests; Toxicology; Turbinates - drug effects; Turbinates - pathology; Various organic compounds; Short term; Rat; Upper respiratory tract; Respiratory disease; Aliphatic compound; Toxicity; Interspecific comparison; Rodentia; Sex; Long term; Inhalation; Dose activity relation; Vertebrata; Chronic; Mammalia; Mouse; Animal; Nasal fossa; Enone
• ISSN: 1096-6080; 1096-0929; 1096-0929
• DOI: 10.1093/toxsci/58.1.182

The National Toxicology Program is conducting a chemical class study to investigate the structure-activity relationships for the toxicity of alpha,beta-unsaturated ketones. Methylvinyl ketone (MVK) was selected for study because it is a representative straight-chain aliphatic alpha,beta-unsaturated ketone and because of its extensive use and widespread exposure. Short-term inhalation studies of MVK were conducted to provide toxicity data for comparison with other alpha,beta-unsaturated ketones and for use in designing chronic toxicity and carcinogenicity studies. In 2-week studies, rats and mice were exposed to 0, 0.25, 0.5, 1, 2, 4, or 8 ppm MVK 6 h/day, 5 days/week for 12 exposures. Morbidity and early deaths occurred in all male and female rats after 1 exposure and in 2 male mice after 10 exposures to 8 ppm. Rats exhibited nasal cavity toxicity and lung necrosis at 4 ppm. No toxicity was observed in animals exposed to less than 2 ppm. Based on these results a 13-week study was conducted at 0, 0.5, 1, and 2 ppm MVK. As observed in the 2-week study, the nasal cavity was the main target organ and rats were more sensitive than mice. Respiratory and olfactory epithelial necrosis were prominent by day 21 in the rat. At study termination these lesions were still evident but not as severe as noted earlier. Additionally, changes such as olfactory epithelial regeneration and metaplasia (respiratory) as well as respiratory epithelial hyperplasia and metaplasia (squamous) were clearly evident. Nasal lesions in mice were limited to a subtle squamous metaplasia of transitional and/or respiratory epithelium covering predominantly the tips of naso- and maxilloturbinates in Levels I and II. A transient, leukopenia was observed in rats exposed to 2 ppm, however, this effect was not present after 13 weeks of exposure. In mice, leukocyte counts were significantly decreased at all exposure concentrations after 13 weeks of exposure. Absolute testicular and epididymal weights and sperm counts were decreased at the high dose only. MVK can be characterized as a reactive, direct-acting gaseous irritant. MVK exposure causes the same nasal cavity lesions as the cyclic alpha,beta-unsaturated ketone, 2-cyclohexen-1-one, although at lower exposure concentrations.